The data provided on this page is updated by the organisations.
The WMDA makes no representations or express or implied warranties regarding any information on this page.
Use of any information provided on this site does not and is not intended to create a contractual or other relationship.
Organisation name: JMDP - Japan Marrow Donor Program Organisation ION: ION-4364 Country: Japan Year the registry started operations: 12/18/1991
comment Do you provide HPC, Marrow?
Do you provide HPC, Apheresis?
Do you provide HPC, Cord Blood?
Do you provide MNC, Apheresis?
Do you provide NC, Whole Blood?
Data valid for year 2020 Number of products National International HPC, Marrow products:
1 HPC, Apheresis:
1 HPC, Cord:
Organisation is licensed/accredited by the Competent Authority: yes Comment: Name of Competent Authority: Ministry of Health, Labor and Welfare Date of last inspection: 3/18/2014 Link to website of Competent Authority: http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/ishoku/index.html Can you provide the Legal documentation from the Competent Authority that your organisation is allowed to operate as a registry ? yes Is your registry WMDA Certified, WMDA Qualified or WMDA Accredited? WMDA Accredited The registry is accredited by any other organisation: no If yes, by which organisation?
The registry works with the following number of affiliated donor centres: 7 The registry audits its donor centres: No, the DCs belong to JMDP The registry works with the following numer of affiliated collection centres: PB:125 BM:194 Ther registry audits its collection centres: Yes The registry works with the following number of affiliated Cord Blood Banks: 0 The registry audits its Cord Blood Banks: No The registry works with the following number of affiliated transplant centres: 249 The registry audits its transplant centres: No The registry works with the following number of affiliated IDM Testing Laboratories: 1 The registry audits its IDM Testing Laboratories: No The registry works with the following number of affiliated HLA/other DNA markers testing laboratories: 2 The registry audits its HLA/other DNA markers testing laboratories: No The registry would be able to provide a full list of name/addresses of each affiliated and their licence/accreditation status, on request: yes The Cord Blood Banks are FACT-NetCord accredited: If yes, the following Cord Blood Bank(s) are accredited: The registry is able to provide a copy of all the certificates: Affiliated centres comply with WMDA Standards and applicable national regulations: yes The registry has requirements for affiliated centres in addition to WMDA Standards and applicable national regulations: If yes, what are these requirements? When a collection center has been certified as a JMDP collection center, that means they meet all the WMDA standards chapter 6-9. We will not include WMDA standards in future contracts with collection centers because of this. JMDP’s CC/AC must be defined by the Medical Care Act (Act No. 205 of 1948), which is from the Ministry of Health, Labor and Welfare. That means CC/AC clear very strict regulation.
All donors are unpaid volunteers: yes All donors are informed about donation process and associated risks: yes Donors sign a valid informed consent to donate in the presence of a medical doctor/health care personnel/registry staff: yes The registry has systems in place to protect and control access to donor/patient records: yes The registry maintains donor anonymity: yes The registry has detailed donor evaluation and exclusion criteria in place: yes The registry has donor evaluation and exclusion criteria that do meet or exceed the WMDA guidelines: yes
The party providing the cell product must exclude donors when:
The physical and medical exam at donor workup is performed by a medical doctor: yes All donor testing (at workup) for infectious disease is performed in a laboratory certified/licensed by a Competent Authority: yes HLA typing for patient specific request is performed in an appropriately accredited laboratory: yes Sterility testing is performed on the adult donor product: no Sterility testing is performed on the cord blood product: Screening questionnaire to exclude communicable disease: yes Screening questionnaire to exclude donors with 'high risk' lifestyles: Donor reliability identified by a medical doctor: yes Donor clearance to donate is confirmed by a medical doctor, following as a minimum the donor exclusion criteria in Annex 1 of EU Directive 2006/17/EC :
Are there any customs regulations to follow, or customs paperwork required, to import cell products into the organisation country? If yes, please specify: No Are there any customs regulations to follow, or customs paperwork required, to export cell products from the organisation country? If yes, please specify: No Are there any import regulations to follow, or paperwork required, to import cell products into the organisation country? If yes, please specify: No Are there any export regulations to follow, or paperwork required, to export cell products from the organisation country? If yes, please specify: No
Reporting of Serious Adverse Events
Please indicate which of the following schemes for reporting Serious Adverse Events relating to either the Donor or the product the Registry participates in: - Mandatory National Reporting Scheme yes - Voluntary National Reporting Scheme yes - WMDA SEAR/SPEAR Reporting Scheme yes The registry will notify the receiving Registry within 24 hours of receiving information relating to any serious adverse event that could be considered to affect the patient receiving the product:
The registry does maintain Standard Operating Procedures for your work: yes The registry would be willing to provide these to WMDA or another registry upon request: yes The registry would be willing to provide WMDA or another registry, on request, with copies of any packaging the HPC product will arrive in: Donor records relating to the medical exam and HPC collection process are the following number(s) of year(s) retained: 35 years
The party providing the cell product must exclude donors when:
Days between test
ALT/ASTALT/AST ratio, De-Ritis-Quotient
Yes Japan Society of Clinical Chemistry (JSCC) method ChagasChagas, T. cruzi
No CMV IgGCytomegalovirus (CMV) Antibody testing IgG
Yes EIA CMV IgMCytomegalovirus (CMV) Antibody testing IgM
On request EIA CMV TotalCytomegalovirus Total
Yes EIA EBV IgGEpstein-Barr Virus Antibody testing IgG
On request FA, EIA EBV IgMEpstein-Barr Virus Antibody testing IgM
On request EIA HAV (NAT)Anti-hepatitis A virus nucleic acid testing
- HBV (NAT)Hepatitis B nucleic acid testing
On request PCR HBc AbHepatitis B core antibody testing
Yes PHA HBs AgHepatitis B Surface antigen testing
Yes CLEIA HCV (NAT)Hepatitis C nucleic acid testing
On request RT-PCR HCV AbHepatitis C antibody testing
Yes CLEIA HEV (NAT)Hepatitis E Virus nucleic acid testing
- HIV (NAT)Human Immunodeficiency Virus nucleic acid testing
On request RT-PCR HIV-1 AbHuman Immunodeficiency Virus HIV-1 antibody testing
Yes CLEIA HIV-2 AbHuman Immunodeficiency Virus HIV-2 antibody testing
Yes CLEIA HIV p24Human Immunodeficiency Virus p24 antigen testing
On request HTLV-IHuman T-Lymphotropic Virus type I testing
Yes LIA HTLV-IIHuman T-Lymphotropic Virus type II testing
No HSVHerpes Simplex Virus
- STSSerological tests for syphilis
Yes LA STS FTA-ABSSerological test for syphilis
On request FA ToxoplasmosisToxoplasmosis
On request ELISA VZVVaricella Zoster Virus
On request PCR WNV-NATWest Nile Virus nucleic acid testing
On request Other tests performed